COVID-19 pooling test method from Ben-Gurion U. IDs asymptomatic carriers

BEER-SHEVA, Israel, August 21, 2020 – A new peer-reviewed study published in Science Advances confirms the success of a new COVID-19 pooling test that identifies all positive subjects, including asymptomatic carriers, in a single round of testing. P-BEST, an algorithmic…

A new tool to create chemical complexity from fatty acids

A new catalyst design enables unprecedented control over the modification of fatty acid derivatives that opens the door to creating useful substances in a green and efficient manner. Hokkaido University WPI-ICReDD researchers developed a modular catalyst that can accurately modify…

Stopping tooth decay before it starts — without killing bacteria

WASHINGTON, Aug. 17, 2020 — Oral bacteria are ready to spring into action the moment a dental hygienist finishes scraping plaque off a patient’s teeth. Eating sugar or other carbohydrates causes the bacteria to quickly rebuild this tough and sticky…

Novateur Ventures explores new strategy to reduce hyperinflammatory response caused by COVID-19

A novel strategy has been developed by Novateur Ventures , which provides new hope in battle against COVID-19. The study titled ‘A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes’ was published in Frontiers in Pharmacology,…

Space invaders as MOFs act as liquids

Innovative materials called metal organic frameworks (MOFs) could become much more versatile following research that shows that they can be manipulated as liquids. MOFs are highly porous crystalline solids with metal ions or metal clusters joined by organic (carbon-based) linker…

SFU chemist’s new process fast-tracks drug treatments for viral infections and cancer

Discovering antiviral and anticancer drugs will soon be faster and cheaper thanks to new research from Simon Fraser University chemist Robert Britton and his international team. For the past 50 years, scientists have used manmade, synthetic and nucleoside analogues to…

UArizona health sciences researcher studies statins for stroke therapy

A $2.8 million grant seeks improved treatment for acute ischemic stroke patients to let them recover faster with fewer long-term complications. It hinges on delivering statins to the brain, where their neuroprotective properties may save damaged tissue

Decoy receptor neutralizes coronavirus in cell cultures

As the COVID-19 pandemic continues to spread, scientists and health care providers are seeking ways to keep the coronavirus from infecting tissues once they’re exposed. A new study suggests luring the virus with a decoy – an engineered, free-floating receptor…

Scientists race to develop an effective COVID-19 vaccine

With the global pandemic still in full swing, scientists are working to develop a vaccine in record time. While everyone wants an effective vaccine, they don’t all agree on how to get there and what “effective” really means. Chemical &…

Current Nanomaterials indexed in Scopus

Current Nanomaterials journal, published by Bentham Science Publishers, has been accepted for inclusion in Scopus. Scopus is the largest abstract and citation database of peer-reviewed literature including scientific journals, books and conference proceedings. Current Nanomaterials , a peer reviewed journal…

Current Nanomaterials indexed in Scopus

Current Nanomaterials journal, published by Bentham Science Publishers, has been accepted for inclusion in Scopus. Scopus is the largest abstract and citation database of peer-reviewed literature including scientific journals, books and conference proceedings. Current Nanomaterials , a peer reviewed journal…

Spraying ethanol to nanofiber masks makes them reusable

As the COVID-19 pandemic spreads around the world, masks have become an essential personal hygiene product as the first line of defense to protect one’s respiratory system against the viruses and germs that spread through droplets in the air. It’s…

$400,000 SBIR grant fast-tracks new approach to treating lung, thyroid cancers

WEST LAFAYETTE, Ind. – A novel approach to treating lung and thyroid cancers is moving closer to clinical trials. A $399,933 SBIR Phase I grant from the National Cancer Institute to KinaRx, a Purdue University-affiliated startup, will help to advance…

Cellular nanosponges could soak up SARS-CoV-2

Scientists are working overtime to find an effective treatment for COVID-19, the illness caused by the new coronavirus, SARS-CoV-2. Many of these efforts target a specific part of the virus, such as the spike protein. Now, researchers reporting in Nano…

Cellular nanosponges could soak up SARS-CoV-2

Scientists are working overtime to find an effective treatment for COVID-19, the illness caused by the new coronavirus, SARS-CoV-2. Many of these efforts target a specific part of the virus, such as the spike protein. Now, researchers reporting in Nano…

RCSI researchers find potential new way to improve treatment for common bleeding disorder

Scientists have found a potential new way to promote blood clotting that could be used to help develop treatments for Von Willebrand Disease, the most common genetic bleeding disorder. The study, led by researchers at RCSI University of Medicine and…

RCSI researchers find potential new way to improve treatment for common bleeding disorder

Scientists have found a potential new way to promote blood clotting that could be used to help develop treatments for Von Willebrand Disease, the most common genetic bleeding disorder. The study, led by researchers at RCSI University of Medicine and…